ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg (Sevicontrol-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01611077
Recruitment Status : Completed
First Posted : June 4, 2012
Last Update Posted : February 23, 2017
Sponsor:
Information provided by (Responsible Party):
Institut für Pharmakologie und Präventive Medizin

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2012
  Actual Study Completion Date : January 2013